Abstract

The X-linked form of Charcot–Marie–Tooth disease (CMT1X) is the second most common form of hereditary motor and sensory neuropathy. The clinical phenotype is characterised by progressive muscle atrophy and weakness, areflexia, variable sensory abnormalities and central nervous system manifestations. Neurophysiology shows intermediate slowing of conduction and distal axonal loss. Nerve biopsies show more prominent axonal degeneration than de- and remyelination. More than 400 different mutations in GJB1, the gene that encodes the gap junction (GJ) protein connexin 32 (Cx32), are known cause of CMT1X. An effective therapy remains to be developed.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.